BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 7035869)

  • 1. Tuftsin, Thr-Lys-Pro-Arg. Anatomy of an immunologically active peptide.
    Fridkin M; Gottlieb P
    Mol Cell Biochem; 1981 Dec; 41():73-97. PubMed ID: 7035869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuftsin and some analogs: synthesis and interaction with human polymorphonuclear leukocytes.
    Fridkin M; Stabinsky Y; Zakuth V; Spirer Z
    Biochim Biophys Acta; 1977 Jan; 496(1):203-11. PubMed ID: 576412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide fragments from the tuftsin containing domain of immunoglobulin G synthesis and biological activity.
    Gottlieb P; Tzehoval E; Feldman M; Segal S; Fridkin M
    Biochem Biophys Res Commun; 1983 Aug; 115(1):193-200. PubMed ID: 6311202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
    Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
    Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuftsin analogues: synthesis, structure-function relationships, and implications for specificity of tuftsin's bioactivity.
    Dagan S; Gottlieb P; Tzehoval E; Feldman M; Fridkin M; Yasumura K; Okamoto K; Yajima H
    J Med Chem; 1986 Oct; 29(10):1961-8. PubMed ID: 3761314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuftsin: its chemistry, biology, and clinical potential.
    Fridkin M; Najjar VA
    Crit Rev Biochem Mol Biol; 1989; 24(1):1-40. PubMed ID: 2667894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tuftsin--new analogues and properties].
    Wardowska A; Dzierzbicka K; Myƛliwski A
    Postepy Biochem; 2007; 53(1):60-5. PubMed ID: 17718389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical and physiological aspects of tuftsin deficiency syndromes exhibiting defective phagocytosis.
    Najjar VA
    Klin Wochenschr; 1979 Aug; 57(15):751-6. PubMed ID: 385971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of the effect of tuftsin and its analogs on immunogenesis].
    Val'dman AV; Ratnikov VI; Makarova NV; Kozlovskaia MM
    Biull Eksp Biol Med; 1982 Dec; 94(12):56-7. PubMed ID: 6897519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal activity of tuftsin.
    Martinez J; Winternitz F
    Mol Cell Biochem; 1981 Dec; 41():123-36. PubMed ID: 6799777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical aspects of tuftsin deficiency syndrome.
    Najjar VA
    Med Biol; 1981 Jun; 59(3):134-8. PubMed ID: 6895538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuftsin, a natural activator of phagocyte cells: an overview.
    Najjar VA
    Ann N Y Acad Sci; 1983; 419():1-11. PubMed ID: 6370072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phagocytosis stimulating peptide tuftsin: further look into structure-function relationships.
    Stabinsky Y; Gottlieb P; Fridkin M
    Mol Cell Biochem; 1980 May; 30(3):165-70. PubMed ID: 6893216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of anti-tuftsin antibody on the phagocytosis of bacteria by human neutrophils.
    Naim JO; Lanzafame RJ; van Oss CJ
    Immunol Invest; 1991; 20(5-6):499-506. PubMed ID: 1791037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells.
    Tzehoval E; Segal S; Stabinsky Y; Fridkin M; Spirer Z; Feldman M
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3400-4. PubMed ID: 277940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of radiolabeled tuftsin with human neutrophils.
    Nair RM; Ponce B; Fudenberg HH
    Immunochemistry; 1978 Dec; 15(12):901-7. PubMed ID: 582033
    [No Abstract]   [Full Text] [Related]  

  • 17. Approaches to some biochemical mechanisms of action of tuftsin and analogues.
    Kraus-Berthier L; Ferry G; Combe-Perez V; Visalli M; Remond G; Vincent M; Boutin JA
    Biochem Pharmacol; 1991 May; 41(10):1411-8. PubMed ID: 1850275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific binding sites for the phagocytosis stimulating peptide tuftsin on human polymorphonuclear leukocytes and monocytes.
    Stabinsky Y; Gottlieb P; Zakuth V; Spirer Z; Fridkin M
    Biochem Biophys Res Commun; 1978 Jul; 83(2):599-606. PubMed ID: 581265
    [No Abstract]   [Full Text] [Related]  

  • 19. The lack of antigenicity of tuftsin: a naturally occurring phagocytosis stimulating tetrapeptide.
    Naim JO; Hinshaw JR; van Oss CJ
    Immunol Invest; 1989 Jul; 18(6):817-24. PubMed ID: 2475442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced phagocytosis activity of cyclic analogs of tuftsin.
    Nishioka K; Obeyesekere NU; McMurray JS
    Biochem Pharmacol; 1995 Mar; 49(5):735-8. PubMed ID: 7887989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.